Your browser doesn't support javascript.
No evidence of clinical efficacy of famotidine for the treatment of COVID-19 in a systematic review and meta-analysis.
Cheema, Huzaifa Ahmad; Shafiee, Arman; Athar, Mohammad Mobin Teymouri; Shahid, Abia; Awan, Rehmat Ullah; Afifi, Ahmed M; Shah, Jaffer; Jalal, Prasun K.
  • Cheema HA; Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Lahore, Pakistan. Electronic address: huzaifacheema@kemu.edu.pk.
  • Shafiee A; Clinical Research Development Unit, Alborz University of Medical Sciences, Karaj, Iran; Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
  • Athar MMT; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shahid A; Division of Infectious Diseases, Department of Medicine, King Edward Medical University, Lahore, Pakistan.
  • Awan RU; Department of Medicine, Ochsner Rush Medical Center, Meridian, MS, United States.
  • Afifi AM; Department of Gastroenterology, Hepatology & Nutrition, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Shah J; New York State Department of Health, Albany, NY, United States.
  • Jalal PK; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, United States.
J Infect ; 2022 Nov 30.
Article in English | MEDLINE | ID: covidwho-2228764
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Language: English Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Language: English Year: 2022 Document Type: Article